Ongoing characterization of AD and other neurodegenerative disorders have revealed that therapeutic manipulation of the heme oxygenase/biliverdin reductase (HO/BVR) system holds enormous potential for prevention and remediation of these diseases. The gene discussed is HMOX1; the disease is Alzheimer disease.